Increased transcapillary escape rate of albumin in patients with cirrhosis of the liver
- PMID: 594644
- DOI: 10.3109/00365517709100658
Increased transcapillary escape rate of albumin in patients with cirrhosis of the liver
Abstract
The transcapillary escape rate of albumin (TERalb), i.e. the fraction of intravascular mass of albumin that passes to the extravascular space per unit time, was determined from the disappearance of intravenously injected 125I-labelled human serum albumin during the first 60 min after injection in nine patients with cirrhosis of the liver. Six of the patients had ascites. The wedged hepatic venous pressure or splenic pulp pressure ranged from 20 to 30 mmHg, mean 26 mmHg. Plasma albumin concentration was low, but plasma volume was slightly enlarged, and thus the intravascular mass of albumin was only moderately reduced. The transcapillary escape rate of albumin was significantly elevated in all the cirrhotics, mean 10.2%/h, range 8.8 to 12.3%/h, in comparison to values for twenty-eight normal subjects 5.4%/h, range 3.5-7.2%/h. Our results can best be explained by increased filtration out of the vessels in the portal system, due to the increased portal venous pressure. The increased TERalb probably contributes to the formation of oedema and ascitic fluid.
Similar articles
-
Filtration as the main mechanism of increased protein extravasation in liver cirrhosis.Scand J Clin Lab Invest. 1980 Apr;40(2):121-8. doi: 10.3109/00365518009093013. Scand J Clin Lab Invest. 1980. PMID: 7256180
-
The effect of ascitic fluid hydrostatic pressure on albumin extravasation rate in patients with cirrhosis of the liver.Scand J Clin Lab Invest. 1981 Oct;41(6):601-9. doi: 10.3109/00365518109090504. Scand J Clin Lab Invest. 1981. PMID: 7336126
-
Transcapillary escape rate of albumin and right atrial pressure in chronic congestive heart failure before and after treatment.Circ Res. 1976 Sep;39(3):358-62. doi: 10.1161/01.res.39.3.358. Circ Res. 1976. PMID: 954165
-
Dual effect of insulin on plasma volume and transcapillary albumin transport.Diabetologia. 1992 Feb;35(2):99-103. doi: 10.1007/BF00402539. Diabetologia. 1992. PMID: 1547928 Review.
-
Changing concepts of albumin metabolism and distribution in cirrhosis of the liver.Scand J Gastroenterol Suppl. 1970;7:17-23. Scand J Gastroenterol Suppl. 1970. PMID: 4917038 Review. No abstract available.
Cited by
-
Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives: Chapter 5 Human Albumin - Revised.Transfus Med Hemother. 2016 May;43(3):223-32. doi: 10.1159/000446043. Epub 2016 May 3. Transfus Med Hemother. 2016. PMID: 27403094 Free PMC article.
-
Pharmacokinetic Considerations for Antibody-Drug Conjugates against Cancer.Pharm Res. 2017 Dec;34(12):2579-2595. doi: 10.1007/s11095-017-2259-3. Epub 2017 Sep 18. Pharm Res. 2017. PMID: 28924691 Review.
-
Lymphatic dysfunction in advanced cirrhosis: Contextual perspective and clinical implications.World J Hepatol. 2021 Mar 27;13(3):300-314. doi: 10.4254/wjh.v13.i3.300. World J Hepatol. 2021. PMID: 33815674 Free PMC article. Review.
-
Population PBPK modelling of trastuzumab: a framework for quantifying and predicting inter-individual variability.J Pharmacokinet Pharmacodyn. 2017 Jun;44(3):277-290. doi: 10.1007/s10928-017-9515-3. Epub 2017 Mar 4. J Pharmacokinet Pharmacodyn. 2017. PMID: 28260166
-
[Guidelines on therapy with blood components and plasma derivatives: human albumin. Recommendations of the scientific advisory board of the Medical Council].Anaesthesist. 2010 Jun;59(6):566-74. doi: 10.1007/s00101-010-1734-6. Anaesthesist. 2010. PMID: 20490440 Review. German.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources